Welcome to a free lunch webinar hosted by Professor Dorota Religa on Current Clinical Status of Amyloid-targeting Therapy for Alzheimer’s Disease.
Find out more about limitations as well as potential utility of amyloidtargeting approaches to slow the progression of Alzheimer’s Disease (AD). The amyloid-targeting drugs can change the course of AD in selected population at the early stages. At the same time, treatments have also been shown to have significant side effects. Even health economic aspects need to be considered.
The previous and current fellows from the Master´s Courses in Dementia Care for Physicians are also invited to the webinar to discuss how the clinics are prepared for future challenges in diagnosis and treatment of AD. A brief Information about the forthcoming course will also be given at the end of the webinar.
During the presentation, there will also be an opportunity to ask questions about the course via chat.
The event is prepared in collaboration with (Swedish registry for cognitive/dementia disorders (SveDem).
SPEAKERS
Dorota Religa, Professor in Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet. Theofanis Tsevis, PhD, affiliated to research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet. Current participant of the Master’s Courses in Dementia Care for Physicians and future Silvia Doctor.
